1Salomoni P, Pandolfi PP. The role of PML in tumor suppression.Cell, 2002; 108:165- 170
2Weis K, Rambaud S, Lavau C, et al . Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell, 1994; 76:345-356
3Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood, 1999; 93:3167 - 3215
4Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 1988; 72:567 - 572
5Wang ZY, Sun GL, Lu JX, et al . Treatment of acute promyelocytic leukemia with all-trans retinoic acid in China. Nouv Rev Fr Hematol, 1990; 32:34 -36
7Guidez F, Ivins S, Zhu J, et al . Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood, 1998; 91:2634-2642
8Lin RJ, Nagy L, Inoue S, et al . Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature, 1998; 391:811- 814
9Grignani F, De-Matteis S, Nervi C, et al . Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature, 1998; 391:815 - 818
10Liu TX, Zhang JW, Tao J, et al . Gene Expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood, 2000; 96: 1496- 1504
